Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad A Reichard

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
European Urology Focus|July 4, 2019
Management of cT4 Prostate CancerWeranja K B Ranasinghe, Chad A Reichard, Tharakeswara Bathala, et al.
Urology|June 19, 2016
A Case of Prostate Cancer in Lynch SyndromeJj Haijing Zhang, Chad A Reichard, Thomas P Plesec, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 24, 2018
Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinomaJonathan J Duplisea, Ross J Mason, Chad A Reichard, et al.
JAMA Oncology|October 20, 2017
Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate CancerJason W D Hearn, Wanling Xie, Mari Nakabayashi, et al.
European Urology|April 7, 2021
Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate CarcinomaOluchi Oke, Weranja Ranasinghe, Chad Tang, et al.
BJU International|April 23, 2019
Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatmentChad A Reichard, Karen E Hoffman, Chad Tang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2021
Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial CohortChad A Reichard, Bryan D Naelitz, Zeneng Wang, et al.
European Urology Focus|May 12, 2019
Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial DesignChad A Reichard, Janet Kukreja, Justin R Gregg, et al.
European Urology|April 17, 2018
Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life OutcomesChad A Reichard, Justin R Gregg, Mary F Achim, et al.
Prostate Cancer and Prostatic Diseases|September 11, 2019
Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancerJanet Baack Kukreja, Tharakeswara K Bathala, Chad A Reichard, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Urology Focus|July 4, 2019
Management of cT4 Prostate CancerWeranja K B Ranasinghe, Chad A Reichard, Tharakeswara Bathala, et al.
Urology|June 19, 2016
A Case of Prostate Cancer in Lynch SyndromeJj Haijing Zhang, Chad A Reichard, Thomas P Plesec, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 24, 2018
Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinomaJonathan J Duplisea, Ross J Mason, Chad A Reichard, et al.
JAMA Oncology|October 20, 2017
Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate CancerJason W D Hearn, Wanling Xie, Mari Nakabayashi, et al.
European Urology|April 7, 2021
Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate CarcinomaOluchi Oke, Weranja Ranasinghe, Chad Tang, et al.
BJU International|April 23, 2019
Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatmentChad A Reichard, Karen E Hoffman, Chad Tang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2021
Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial CohortChad A Reichard, Bryan D Naelitz, Zeneng Wang, et al.
European Urology Focus|May 12, 2019
Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial DesignChad A Reichard, Janet Kukreja, Justin R Gregg, et al.
European Urology|April 17, 2018
Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life OutcomesChad A Reichard, Justin R Gregg, Mary F Achim, et al.
Prostate Cancer and Prostatic Diseases|September 11, 2019
Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancerJanet Baack Kukreja, Tharakeswara K Bathala, Chad A Reichard, et al.
Pageof 3